Fmr LLC boosted its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 5.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,056,774 shares of the medical instruments supplier’s stock after purchasing an additional 436,031 shares during the period. Fmr LLC owned approximately 4.56% of DENTSPLY SIRONA worth $245,076,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in XRAY. Scientech Research LLC acquired a new position in DENTSPLY SIRONA in the second quarter valued at $846,000. VELA Investment Management LLC acquired a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at about $2,168,000. M&G Plc acquired a new position in shares of DENTSPLY SIRONA in the 2nd quarter valued at about $8,817,000. Empowered Funds LLC purchased a new stake in shares of DENTSPLY SIRONA during the 3rd quarter worth about $2,468,000. Finally, Country Club Bank acquired a new stake in DENTSPLY SIRONA during the 3rd quarter worth approximately $4,084,000. Institutional investors and hedge funds own 95.70% of the company’s stock.
DENTSPLY SIRONA Stock Up 0.1 %
Shares of NASDAQ XRAY opened at $19.65 on Monday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $37.60. The stock’s 50-day simple moving average is $22.55 and its 200-day simple moving average is $24.74. The firm has a market cap of $3.91 billion, a price-to-earnings ratio of -9.49, a PEG ratio of 1.93 and a beta of 1.02.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on XRAY shares. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Robert W. Baird lowered their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, November 8th. Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, Evercore ISI lowered their target price on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Seven research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $29.50.
Read Our Latest Research Report on XRAY
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Articles
- Five stocks we like better than DENTSPLY SIRONA
- Short Selling: How to Short a Stock
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- How to Invest in Insurance Companies: A Guide
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- About the Markup Calculator
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.